Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Expected to Rise, Truist Financial Analyst Says
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price objective increased by analysts at Truist Financial from $42.00 to $45.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price would indicate a potential upside of 28.58% from the stock’s previous close. […]
2 May 08:43 · The Cerbat Gem